Date | Time | Source | Headline | Symbol | Company |
04/24/2024 | 1:23AM | Business Wire | GoFundMe se expande a México | | |
04/24/2024 | 1:20AM | Business Wire | Air Liquide continues its trajectory with another solid quarter, combining sales growth, performance improvement and investment momentum | NYSE:AI | C3 AI Inc |
04/24/2024 | 1:20AM | Business Wire | Air Liquide poursuit sa trajectoire en réalisant à nouveau un trimestre solide, combinant croissance des ventes, amélioration de la performance et dynamique d'investissement | NYSE:AI | C3 AI Inc |
04/24/2024 | 1:18AM | PR Newswire (Canada) | Xinhua Silk Road : La marque chinoise de baijiu Wuliangye met en lumière les échanges culturels entre la Chine et le Chili par l'entremise d'une tournée mondiale élaborée | | |
04/24/2024 | 1:15AM | Business Wire | Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives | NYSE:ERF | Enerplus Corporation |
04/24/2024 | 1:03AM | Business Wire | Kalray Joins Arm Total Design, Extending Collaboration With Arm on Accelerated AI Processing | EU:ALKAL | KALRAY SA |
04/24/2024 | 1:03AM | Business Wire | KALRAY DEVIENT MEMBRE DU PROGRAMME « ARM TOTAL DESIGN », RENFORÇANT SA COLLABORATION AVEC ARM SUR L’IA ET L’ACCÉLÉRATION DU TRAITEMENT DES DONNÉES | EU:ALKAL | KALRAY SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | NaaS Technology and its Parent Company, NewLink, Join the Open Invention Network Community | NASDAQ:NAAS | NaaS Technology Inc |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestre | TG:MEX | Melexis |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | IMCD Spain expands its Pharmaceuticals presence with the acquisition of Cobapharma | TG:INX | IMCD NV |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Melexis Q1 2024 results – First quarter sales of 241.8 million EUR | EU:MELE | Melexis |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen delivers strong sales in the first quarter of 2024, driven by growth platforms & new medicines, and confirms its full-year guidance | EU:IPN | Ipsen SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Melexis Q1 2024 résultats – Chiffre d'affaires de 241.8 millions d'euros au premier trimestre | EU:MELE | Melexis |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | BioSenic postpones its annual general meeting of the shareholders and provides temporary non-audited financial figures for 2023 | EU:BIOS | Biosenic |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | First quarter 2024 financial information: Good start to the year | EU:NEX | Nexans |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates | TG:05Y | Vivoryon Therapeut |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates | LSE:0R3M | Vivoryon Therapeutics Nv |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Information financière du premier trimestre 2024: Bon début d'année | EU:NEX | Nexans |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | TGS Q1 2024 Presentation and Webcast | TG:TGC | TGS ASA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Norsk Hydro: Resilient in weak markets, positioned for growth | TG:NHY | Lucapa Diamond Company Ltd |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Vopak reports strong Q1 2024 results and increases FY 2024 outlook | EU:VPK | Koninklijke Vopak |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | BioSenic reporte son assemblée générale annuelle des actionnaires et fournit des chiffres financiers temporaires non-audités pour 2023 | LSE:0R55 | Bone Therapeutics Sa |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Start of Day Message | | |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Ipsen enregistre une solide croissance de ses ventes au premier trimestre et confirme ses objectifs financiers pour l'exercice 2024 | TG:I7G | Ipsen SA |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Melexis Q1 2024 results – First quarter sales of 241.8 million EUR | TG:MEX | Melexis |
04/24/2024 | 1:00AM | Business Wire | CARMAT Announces Its 2023 Annual Results and Provides an Update on Its Progress and Prospects for 2024 | EU:ALCAR | Carmat |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Vivoryon Therapeutics N.V. Reports Full Year 2023 Financial Results and Provides Varoglutamstat and Strategic Updates | EU:VVY | Vivoryon Therapeut |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards | EU:PHARM | Pharming Group NV |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | First quarter 2024 financial information: Good start to the year | EU:NEX | Nexans |
04/24/2024 | 1:00AM | GlobeNewswire Inc. | Information financière du premier trimestre 2024: Bon début d'année | TG:NXS | Nexans |